Mary F. Hoult

Mary F. Hoult

Geen lopende functies

58 jaar
Commercial Services
Health Technology
Consumer Services

Profiel

Ms. Molly Hoult is a Principal at Fletcher Spaght Venture Partners LLC and Independent Director at HTG Molecular Diagnostics, Inc. She is on the Board of Directors at Fletcher Spaght, Inc. and HTG Molecular Diagnostics, Inc. Prior to rejoining the firm in 2009, Ms. Hoult spent over a decade in marketing and business development roles for various biotechnology and medical device firms including: ZymoGenetics, Blue Heron Biotechnology and NeoPath (which subsequently merged to form TriPath and then was acquired by BD Diagnostics).
Ms. Hoult holds an MBA from the Stanford Graduate School of Business and a BA in Biology and Environmental Studies from Dartmouth College.

Eerdere bekende functies van Mary F. Hoult

BedrijvenFunctieEinde
Promidian Private Equity Investor 01-09-2021
Private Equity Investor 01-09-2021
Private Equity Investor 01-04-2019
HTG MOLECULAR DIAGNOSTICS, INC. Directeur/Bestuurslid 01-08-2016
Xcyte Therapies, Inc. Directeur/Bestuurslid -
Ervaring van Mary F. Hoult in detail bekijken

Opleiding van Mary F. Hoult

Dartmouth College Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mary F. Hoult in detail bekijken

Connecties

24

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
HTG MOLECULAR DIAGNOSTICS, INC.

Commercial Services

Bedrijven in privébezit7

Health Technology

Commercial Services

Xcyte Therapies, Inc.

Health Technology

Health Technology

Commercial Services

Commercial Services

Promidian

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mary F. Hoult